<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36075902</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Structure-function analysis of enterovirus protease 2A in complex with its essential host factor SETD3.</ArticleTitle><Pagination><StartPage>5282</StartPage><MedlinePgn>5282</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5282</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-32758-3</ELocationID><Abstract><AbstractText>Enteroviruses cause a number of medically relevant and widespread human diseases with no approved antiviral therapies currently available. Host-directed therapies present an enticing option for this diverse genus of viruses. We have previously identified the actin histidine methyltransferase SETD3 as a critical host factor physically interacting with the viral protease 2A. Here, we report the 3.5 Å cryo-EM structure of SETD3 interacting with coxsackievirus B3 2A at two distinct interfaces, including the substrate-binding surface within the SET domain. Structure-function analysis revealed that mutations of key residues in the SET domain resulted in severely reduced binding to 2A and complete protection from enteroviral infection. Our findings provide insight into the molecular basis of the SETD3-2A interaction and a framework for the rational design of host-directed therapeutics against enteroviruses.</AbstractText><CopyrightInformation>© 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Peters</LastName><ForeName>Christine E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Schulze-Gahmen</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0003-3919-4474</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, The J. David Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckhardt</LastName><ForeName>Manon</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8143-6129</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, The J. David Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Gwendolyn M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0001-7806-9874</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, The J. David Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiewei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, The J. David Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulido</LastName><ForeName>Ernst H</ForeName><Initials>EH</Initials><Identifier Source="ORCID">0000-0002-3616-9743</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, The J. David Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardine</LastName><ForeName>Conner</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craik</LastName><ForeName>Charles S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0001-7704-9185</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5697-1274</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Virology, The J. David Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chan-Zuckerberg Biohub, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gozani</LastName><ForeName>Or</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-1365-4463</Identifier><AffiliationInfo><Affiliation>Department of Biology, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verba</LastName><ForeName>Kliment A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0002-2238-8590</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA. Kliment.Verba@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA. Kliment.Verba@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. Kliment.Verba@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hüttenhain</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0896-5910</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA. Ruth.Huttenhain@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA. Ruth.Huttenhain@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, The J. David Gladstone Institutes, San Francisco, CA, USA. Ruth.Huttenhain@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. Ruth.Huttenhain@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carette</LastName><ForeName>Jan E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-5187-8070</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. carette@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krogan</LastName><ForeName>Nevan J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0003-4902-337X</Identifier><AffiliationInfo><Affiliation>QBI Coronavirus Research Group (QCRG), San Francisco, CA, USA. nevan.krogan@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, The J. David Gladstone Institutes, San Francisco, CA, USA. nevan.krogan@ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. nevan.krogan@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AI171421</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI153169</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM145460</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI135990</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AI150476</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI130123</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01 AI000732</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI171110</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI140186</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI141970</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM139569</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D000076983">Histone Methyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.43</RegistryNumber><NameOfSubstance UI="C584641">SETD3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076983" MajorTopicYN="N">Histone Methyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The Krogan laboratory has received research support from F. Hoffmann-La Roche, and the Krogan and Ott laboratories have received research support from Vir Biotechnology. Nevan Krogan has consulting agreements with the Icahn School of Medicine at Mount Sinai, New York, Maze Therapeutics and Interline Therapeutics. He is a shareholder of Tenaya Therapeutics, Maze Therapeutics and Interline Therapeutics, and is financially compensated by GEn1E Lifesciences, Inc. and Twist Bioscience Corp.. Jan Carette has consulted for Janssen BioPharma. Or Gozani is a scientific co-founder, consultant and shareholder of EpiCypher, Inc, and K36 Therapeutics, Inc. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36075902</ArticleId><ArticleId IdType="pmc">PMC9453702</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-32758-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-32758-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg AC, et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science. 2009;324:55–59. doi: 10.1126/science.1165557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165557</ArticleId><ArticleId IdType="pmc">PMC3923423</ArticleId><ArticleId IdType="pubmed">19213880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 2018;17:35–56. doi: 10.1038/nrd.2017.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.162</ArticleId><ArticleId IdType="pmc">PMC7097079</ArticleId><ArticleId IdType="pubmed">28935918</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelmont L, et al. DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A. PLoS ONE. 2010;5:e13687. doi: 10.1371/journal.pone.0013687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013687</ArticleId><ArticleId IdType="pmc">PMC2965138</ArticleId><ArticleId IdType="pubmed">21060866</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, et al. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob. Agents Chemother. 2009;53:1850–1857. doi: 10.1128/AAC.00934-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00934-08</ArticleId><ArticleId IdType="pmc">PMC2681499</ArticleId><ArticleId IdType="pubmed">19237651</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins GM, Rambaut A, Pybus OG, Holmes EC. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 2002;54:156–165. doi: 10.1007/s00239-001-0064-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00239-001-0064-3</ArticleId><ArticleId IdType="pubmed">11821909</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckhardt M, Hultquist JF, Kaake RM, Hüttenhain R, Krogan NJ. A systems approach to infectious disease. Nat. Rev. Genet. 2020;21:339–354. doi: 10.1038/s41576-020-0212-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-020-0212-5</ArticleId><ArticleId IdType="pmc">PMC7839161</ArticleId><ArticleId IdType="pubmed">32060427</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep J, et al. Enterovirus pathogenesis requires the host methyltransferase SETD3. Nat. Microbiol. 2019;4:2523–2537. doi: 10.1038/s41564-019-0551-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0551-1</ArticleId><ArticleId IdType="pmc">PMC6879830</ArticleId><ArticleId IdType="pubmed">31527793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski, S. et al. SETD3 protein is the actin-specific histidine -methyltransferase. Elife7, e37921 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289574</ArticleId><ArticleId IdType="pubmed">30526847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson AW, et al. SETD3 is an actin histidine methyltransferase that prevents primary dystocia. Nature. 2019;565:372–376. doi: 10.1038/s41586-018-0821-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0821-8</ArticleId><ArticleId IdType="pmc">PMC6511263</ArticleId><ArticleId IdType="pubmed">30626964</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards AL, Eckhardt M, Krogan NJ. Mass spectrometry-based protein-protein interaction networks for the study of human diseases. Mol. Syst. Biol. 2021;17:e8792. doi: 10.15252/msb.20188792.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20188792</ArticleId><ArticleId IdType="pmc">PMC7803364</ArticleId><ArticleId IdType="pubmed">33434350</ArticleId></ArticleIdList></Reference><Reference><Citation>Jäger S, et al. Global landscape of HIV-human protein complexes. Nature. 2011;481:365–370. doi: 10.1038/nature10719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10719</ArticleId><ArticleId IdType="pmc">PMC3310911</ArticleId><ArticleId IdType="pubmed">22190034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459–468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, et al. Enteroviral proteases: structure, host interactions and pathogenicity. Rev. Med. Virol. 2016;26:251–267. doi: 10.1002/rmv.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurgens CK, et al. 2Apro is a multifunctional protein that regulates the stability, translation and replication of poliovirus RNA. Virology. 2006;345:346–357. doi: 10.1016/j.virol.2005.09.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.09.067</ArticleId><ArticleId IdType="pubmed">16297952</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Lu H-H, Mueller S, Wimmer E. The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage. J. Gen. Virol. 2001;82:397–408. doi: 10.1099/0022-1317-82-2-397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-82-2-397</ArticleId><ArticleId IdType="pubmed">11161279</ArticleId></ArticleIdList></Reference><Reference><Citation>Nchoutmboube JA, et al. Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles. PLoS Pathog. 2013;9:e1003401. doi: 10.1371/journal.ppat.1003401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003401</ArticleId><ArticleId IdType="pmc">PMC3675155</ArticleId><ArticleId IdType="pubmed">23762027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshii T, et al. A non-catalytic function of SETD1A regulates cyclin K and the DNA damage response. Cell. 2018;172:1007–1021.e17. doi: 10.1016/j.cell.2018.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.01.032</ArticleId><ArticleId IdType="pmc">PMC6052445</ArticleId><ArticleId IdType="pubmed">29474905</ArticleId></ArticleIdList></Reference><Reference><Citation>Perreault A, Gascon S, D’Amours A, Aletta JM, Bachand F. A methyltransferase-independent function for Rmt3 in ribosomal subunit homeostasis. J. Biol. Chem. 2009;284:15026–15037. doi: 10.1074/jbc.M109.004812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.004812</ArticleId><ArticleId IdType="pmc">PMC2685685</ArticleId><ArticleId IdType="pubmed">19359250</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamphear BJ, et al. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J. Biol. Chem. 1993;268:19200–19203. doi: 10.1016/S0021-9258(19)36499-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)36499-3</ArticleId><ArticleId IdType="pubmed">8396129</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H, et al. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat. Methods. 2011;8:70–73. doi: 10.1038/nmeth.1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1541</ArticleId><ArticleId IdType="pmc">PMC3064265</ArticleId><ArticleId IdType="pubmed">21131968</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, H. et al. Analyzing protein-protein interactions from affinity purification-mass spectrometry data with SAINT. Curr. Protoc. BioinformaticsChapter 8, Unit8.15 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3446209</ArticleId><ArticleId IdType="pubmed">22948729</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M, et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics. 2014;30:2524–2526. doi: 10.1093/bioinformatics/btu305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu305</ArticleId><ArticleId IdType="pubmed">24794931</ArticleId></ArticleIdList></Reference><Reference><Citation>Jäger S, et al. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature. 2011;481:371–375. doi: 10.1038/nature10693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10693</ArticleId><ArticleId IdType="pmc">PMC3310910</ArticleId><ArticleId IdType="pubmed">22190037</ArticleId></ArticleIdList></Reference><Reference><Citation>Jäger S, et al. Purification and characterization of HIV-human protein complexes. Methods. 2011;53:13–19. doi: 10.1016/j.ymeth.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC3076283</ArticleId><ArticleId IdType="pubmed">20708689</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu N, Dai L, Nordlund P. CETSA in integrated proteomics studies of cellular processes. Curr. Opin. Chem. Biol. 2020;54:54–62. doi: 10.1016/j.cbpa.2019.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2019.11.004</ArticleId><ArticleId IdType="pubmed">31838273</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CSH, et al. Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells. Science. 2018;359:1170–1177. doi: 10.1126/science.aan0346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan0346</ArticleId><ArticleId IdType="pubmed">29439025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintzen JCJ, et al. β-Actin peptide-based inhibitors of Histidine Methyltransferase SETD3. ChemMedChem. 2021;16:2695–2702. doi: 10.1002/cmdc.202100296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202100296</ArticleId><ArticleId IdType="pubmed">34032009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki J, Ishikawa K, Arita M, Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 2012;31:754–766. doi: 10.1038/emboj.2011.429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.429</ArticleId><ArticleId IdType="pmc">PMC3273392</ArticleId><ArticleId IdType="pubmed">22124328</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL, Knudsen GM, Betegon M, Burlingame AL, DeRisi JL. ACBD3 interaction with TBC1 domain 22 protein is differentially affected by enteroviral and kobuviral 3A protein binding. MBio. 2013;4:e00098–13. doi: 10.1128/mBio.00098-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00098-13</ArticleId><ArticleId IdType="pmc">PMC3622926</ArticleId><ArticleId IdType="pubmed">23572552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo, H. et al. ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB. MBio10, 31993215 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372799</ArticleId><ArticleId IdType="pubmed">30755512</ArticleId></ArticleIdList></Reference><Reference><Citation>Horova V, et al. Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites. PLoS Pathog. 2019;15:e1007962. doi: 10.1371/journal.ppat.1007962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007962</ArticleId><ArticleId IdType="pmc">PMC6695192</ArticleId><ArticleId IdType="pubmed">31381608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Q. et al. Structural insights into SETD3-mediated histidine methylation on β-actin. Elife8, 10.7554/eLife.43676.001 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6400499</ArticleId><ArticleId IdType="pubmed">30785395</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke JE. Structural basis for regulation of phosphoinositide kinases and their involvement in human disease. Mol. Cell. 2018;71:653–673. doi: 10.1016/j.molcel.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.08.005</ArticleId><ArticleId IdType="pubmed">30193094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamarche MJ, et al. Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors. Antimicrob. Agents Chemother. 2012;56:5149–5156. doi: 10.1128/AAC.00946-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00946-12</ArticleId><ArticleId IdType="pmc">PMC3457382</ArticleId><ArticleId IdType="pubmed">22825118</ArticleId></ArticleIdList></Reference><Reference><Citation>Spickler C, et al. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. Antimicrob. Agents Chemother. 2013;57:3358–3368. doi: 10.1128/AAC.00303-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00303-13</ArticleId><ArticleId IdType="pmc">PMC3697394</ArticleId><ArticleId IdType="pubmed">23650168</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaillancourt FH, et al. Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target. J. Virol. 2012;86:11595–11607. doi: 10.1128/JVI.01320-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01320-12</ArticleId><ArticleId IdType="pmc">PMC3486294</ArticleId><ArticleId IdType="pubmed">22896614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat, K. P., Ümit Kaniskan, H., Jin, J. &amp; Gozani, O. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat. Rev. Drug Discov. 10.1038/s41573-020-00108-x (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8035164</ArticleId><ArticleId IdType="pubmed">33469207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma A, et al. Discovery of a first-in-class EZH2 selective degrader. Nat. Chem. Biol. 2020;16:214–222. doi: 10.1038/s41589-019-0421-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-019-0421-4</ArticleId><ArticleId IdType="pmc">PMC6982609</ArticleId><ArticleId IdType="pubmed">31819273</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367–1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JC, Gorenstein MV, Li G-Z, Vissers JPC, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteom. 2006;5:144–156. doi: 10.1074/mcp.M500230-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M500230-MCP200</ArticleId><ArticleId IdType="pubmed">16219938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochman H, Gerber AS, Hartl DL. Genetic applications of an inverse polymerase chain reaction. Genetics. 1988;120:621–623. doi: 10.1093/genetics/120.3.621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/120.3.621</ArticleId><ArticleId IdType="pmc">PMC1203539</ArticleId><ArticleId IdType="pubmed">2852134</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronarde DN. SerialEM: a program for automated tilt series acquisition on tecnai microscopes using prediction of specimen position. Microsc. Microanalysis. 2003;9:1182–1183. doi: 10.1017/S1431927603445911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1431927603445911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216–221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Rosa-Trevín JM, et al. Scipion: A software framework toward integration, reproducibility and validation in 3D electron microscopy. J. Struct. Biol. 2016;195:93–99. doi: 10.1016/j.jsb.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2016.04.010</ArticleId><ArticleId IdType="pubmed">27108186</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani A, Rubinstein JL, Fleet DJ, Brubaker M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 2017;14:290–296. doi: 10.1038/nmeth.4169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4169</ArticleId><ArticleId IdType="pubmed">28165473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan YZ, et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat. Methods. 2017;14:793–796. doi: 10.1038/nmeth.4347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4347</ArticleId><ArticleId IdType="pmc">PMC5533649</ArticleId><ArticleId IdType="pubmed">28671674</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebschner D, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D. Struct. Biol. 2019;75:861–877. doi: 10.1107/S2059798319011471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798319011471</ArticleId><ArticleId IdType="pmc">PMC6778852</ArticleId><ArticleId IdType="pubmed">31588918</ArticleId></ArticleIdList></Reference><Reference><Citation>Croll TI. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. Sect. D. Struct. Biol. 2018;74:519–530. doi: 10.1107/S2059798318002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798318002425</ArticleId><ArticleId IdType="pmc">PMC6096486</ArticleId><ArticleId IdType="pubmed">29872003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, R. Y. -R. et al. Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta. Elife5, (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5115868</ArticleId><ArticleId IdType="pubmed">27669148</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucukelbir A, Sigworth FJ, Tagare HD. Quantifying the local resolution of cryo-EM density maps. Nat. Methods. 2014;11:63–65. doi: 10.1038/nmeth.2727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2727</ArticleId><ArticleId IdType="pmc">PMC3903095</ArticleId><ArticleId IdType="pubmed">24213166</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70–82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn MD, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D. Biol. Crystallogr. 2011;67:235–242. doi: 10.1107/S0907444910045749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910045749</ArticleId><ArticleId IdType="pmc">PMC3069738</ArticleId><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007;372:774–797. doi: 10.1016/j.jmb.2007.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.05.022</ArticleId><ArticleId IdType="pubmed">17681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari R, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 2014;9:2100–2122. doi: 10.1038/nprot.2014.138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.138</ArticleId><ArticleId IdType="pubmed">25101824</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods. 2014;11:783–784. doi: 10.1038/nmeth.3047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3047</ArticleId><ArticleId IdType="pmc">PMC4486245</ArticleId><ArticleId IdType="pubmed">25075903</ArticleId></ArticleIdList></Reference><Reference><Citation>Campeau E, et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS ONE. 2009;4:e6529. doi: 10.1371/journal.pone.0006529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006529</ArticleId><ArticleId IdType="pmc">PMC2717805</ArticleId><ArticleId IdType="pubmed">19657394</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D450. doi: 10.1093/nar/gky1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1106</ArticleId><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanke KHW, et al. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J. Virol. 2009;83:11940–11949. doi: 10.1128/JVI.01244-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01244-09</ArticleId><ArticleId IdType="pmc">PMC2772713</ArticleId><ArticleId IdType="pubmed">19740986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>